HomeStock WatchMomentum StocksPenny Stock ArticlesAboutContact Us
     
   
 

Archive for April, 2012

123456...Last »

Stocks to Watch – Agenus Inc. (AGEN)

Posted on April 30th, 2012 by admin

Stocks to Watch – Agenus Inc. (NASDAQ: AGEN)

Agenus Inc., (Agenus) is a known biotechnology company that concentrates on developing and commercializing technologies for the treatment of cancers and infectious diseases. The Company was previously known as Antigenics Inc. and uses immunological approaches for its products.

The Company’s products and technologies include the following:

  • Heat Shock Protein Technology
  • The Prophage Series of Cancer Vaccines
  • Phase 3 Renal Cell Carcinoma Program
  • Glioma

Its key assets involve the:

  • Prophage Series of cancer vaccines
  • QS-21 Stimulon adjuvant (QS-21)
  • HerpV

This Prophage series of cancer vaccines are based on its core heat shock protein technology. Meanwhile, the QS-21 is an adjuvant and is used as a substance that is added up to any vaccines or immunotherapy that will enhance immune response. Lastly, the HerpV is a therapeutic vaccine for the treatment of genital herpes, which is based on the Company’s Heat shock proteins (HSP) technology.

Heat Shock Protein Technology

This is known as stress proteins wherein the expression is increased when cells experience various stresses like extremes of temperature (hot or cold) and oxygen deprivation.

The Prophage Series of Cancer Vaccines

This is basically the primary product under the Company’s portfolio of patient-specific HSP-based therapeutic cancer vaccines which involves the following:

  • R-Series candidates in renal cell carcinoma (RCC)
  • M-Series candidates in melanoma
  • G-Series candidates in glioma
  • NP-Series candidate in pediatric neurological tumors

Phase 3 Renal Cell Carcinoma Program

The Company started a Phase 3, multicenter, international trial for non-metastatic RCC for the treatment of renal cell carcinoma.

Glioma

This is cancer that affects the central nervous system and begins in the glial cells (connective tissue cells that surround and support nerve cells). This is a fatal disease. The Company has already started a Phase 2 clinical trial with Prophage Series G-200 in recurrent, high-grade glioma is ongoing. This is led by the Brain Tumor Research Center at the University of California, San Francisco (UCSF).

Other Clinical Trials

The Company started the initial clinical trials of Prophage Series vaccines. These are focused on assessing feasibility, safety and preliminary efficacy; select studies measured immune response. Moreover, it also commenced a series of small, single-arm trials were performed in a range of solid tumor types.

Agenus Inc. (NASDAQ: AGEN) 52 week: 1.92 – 7.41   Mkt cap: 141.03M   Shares:  22.49M

Read More

Stocks to Watch – Aerosonic Corporation (AIM)

Posted on April 30th, 2012 by admin

Stocks to Watch – Aerosonic Corporation (NYSEAMEX: AIM)

Aerosonic Corporation (Aerosonic) is a company engaged in the manufacture and sale of aircraft instruments. It was established in 1968. The Company is involved in the design and manufacturing of the following:

  • Mechanical and digital altimeters
  • Airspeed indicators
  • Rate of climb indicators
  • Microprocessor controlled air data test sets,
  • Other flight instrumentation

The Company is also involved in designing and manufacturing of angle of attack (AOA) stall warning systems; integrated multi-function probes (IMFPs). These are integrated air data sensors, and other aircraft sensors and monitoring systems. Its products are marketed to manufacturers of commercial and private aircraft. It also has several domestic and foreign customers. It also supplies the United States military services.

By the year 2011, the Company’s sales for the private sector reached 66%. Moreover, 34% of the sales came from the United States Military services. The Company’s largest customer is was Korea Aerospace Industries, which represented 14% of total revenues. It also sells products to customers not from the United States.

Majority of the Company’s instrument sales are made directly through its sales personnel to original equipment manufacturers (OEMs) or to the United States Military. Its remaining sales on the other hand are made through distributors and commissioned sales representatives who resell to aircraft operators. The Company also manufactures a line of mechanical and electro-mechanical cockpit instruments. These do not need any backup input, as they transfer flight data to the pilot using only air pressure from aircraft probes as a power source.

It is also involved in the production of a line of angle of attack (AOA) stall warning products, including a self-test AOA sensor as well as IMFPs. These combine existing technologies, including the AOA/air data sensing probe and pressure sensing electronics.

The Company has a wide experience in air data products and continues to expand with the development of a flush port air data system for the following:

  • Dassault Aviation nEUROn Unmanned Combat Air Vehicle (UCAV) (with Alenia Aeronautica, a Finmeccanica Company)
  • Level A certification for the Stall Warning Transmitter (SWT) for Hawker Beachcraft Corporation’s Premier II aircraft

The Company produces digital cockpit instruments which integrates the accuracy of digital electronic equipment, with a pilot familiar analog pointer display.

Aerosonic Corporation (NYSEAMEX: AIM) 52 week: 2.07 – 3.48   Mkt cap: 9.12M   Shares: 3.77M

Read More

Stocks to Watch – Aehr Test Systems (AEHR)

Posted on April 30th, 2012 by admin

Stocks to Watch – Aehr Test Systems (NASDAQ: AEHR)

Aehr Test Systems (Aehr Test) is a company involved in the manufacture and sale of systems highly designed for the reduction of the costs in testing flash, dynamic random access memory (DRAM), and other memory devices, and to perform reliability screening, or burn-in, of complex logic and memory devices. It was established on May 25, 1977.

These systems are utilized for performing parallel testing and burn-in of packaged integrated circuits (ICs), singulated bare die or ICs still in wafer form. The Company also developed a range of product families such as the ABTS, FOX, MTX and MAX systems, the WaferPak cartridge and the DiePak carrier.

Its new ABTS family of systems can actually do test during burn-in on both logic and memory packaged ICs. Moreover, the Company is also engaged in the manufacture and marketing of full wafer contact systems, monitored burn-in systems, massively parallel test systems, test fixtures, die carriers and related accessories. These products are marketed all throughout the world mainly to these sectors:

  • Semiconductor manufacturers
  • Semiconductor contract assemblers
  • Electronics manufacturers
  • Burn-in and test service companies

Full Wafer Contact Systems

The Company’s FOX-1 full wafer parallel test system is specifically designed for massively parallel test in wafer sort. This can lead to the generation of electrical contact to and test the entire die on a wafer in a single touchdown. The Company’s FOX-1 test head and WaferPak contactor can be combined with industry-standard 300 millimeter wafer probers. These can provide the wafer handling and alignment automation for the FOX-1 system.

Systems for Packaged Parts

The Company’s monitor burn-in and massively parallel test systems are composed of the following subsystems:

  • Pattern generation and test electronics
  • Control software
  • Network interface
  • Environmental chamber

These massively parallel test systems involve an algorithmic test pattern generator. Moreover, its pin electronics at each burn-in board (BIB), or performance test board (PTB), position are intended for the provision of accurate signals to the memory ICs being tested and detect whether a device is failing the test.

Test Fixtures

The Company is involved in the selling and licensing of custom-designed test fixtures for its systems. These include PTBs for use with the MTX massively parallel test system and BIBs for the MAX monitored burn-in system.

Aehr Test Systems (NASDAQ: AEHR) 52 week: 0.40 – 2.08   Mkt cap: 13.40M   Shares: 9.06M

Read More

Stocks to Watch – AdCare Health Systems Inc. (ADK)

Posted on April 30th, 2012 by admin

Stocks to Watch – AdCare Health Systems Inc. (NYSEAMEX: ADK)

AdCare Health Systems, Inc. (AdCare) is a company involved in the development, ownership and management of the following:

  • Retirement communities
  • Assisted living facilities
  • Nursing homes
  • Provider of home health care services

It currently manages 29 facilities which are composed of the following:

  • 20 skilled nursing centers
  • 8 assisted living residences
  • 1 independent living/senior housing facility

These facilities house a total of over 2,400 units. Moreover, the Company
operates in four business segment:

  • Skilled nursing facilities (SNF)
  • Assisted living facilities (ALF)
  • Home health and management and development

By the year 2010, the Company acquired Community’s Hearth & Home. It also acquired Attalla Health Care and the operations of and selected assets of Coosa Valley Health Care. It also acquired operations of and selected assets of Mountain Trace.

Adcare is also a holding company with fully owned subsidiaries. Through them, the Company provides a full complement of administrative services as well as consultative services that permit its local facility leadership teams to focus on the delivery of healthcare services. It also offers services to unaffiliated third party long term care operators owners with whom it enters into contracts.

The Company also has ownership interest in the 10 facilities it manages. All of these are fully owned by Adcare. The ten is composed of:

  • Four of the skilled nursing centers
  • Six assisted living facilities

Skilled Nursing Facility Segment

It actually concentrates on two primary indicators to evaluate the financial performance in this segment. Those are facility occupancy and staffing. Facility staffing involves payroll and related payroll costs. Meanwhile, staffing levels can be monitored through making sure that costs are maintained.

Assisted Living Facility Segment

This segment focuses on facility occupancy and staffing. It has already been through several initiatives for census, such as advertising campaigns, a sales incentive system and multiple public events at facilities to increase community interaction and facility visibility.

Home Based Care Segment

This segment offers health care services to patients in their homes 19.8% of the Company’s home health patients are covered by Medicare.

Management, Development and Corporate Segment

Through this segment, the Company manages five skilled nursing facilities, two assisted living facilities and one independent living campus for third party owners.

AdCare Health Systems, Inc. (NYSEAMEX: ADK) 52 week: 3.35 – 6.37   Mkt cap: 47.64M   Shares: 13.31M

Read More

Stocks to Watch – Actuate Corporation (BIRT)

Posted on April 30th, 2012 by admin

Stocks to Watch – Actuate Corporation (NASDAQ: BIRT)

Actuate Corporation (Actuate) is a company engaged in providing software and services for the development and deployment of custom Business Intelligence and information applications. It was established in November 1993. The Company’s applications were built on Actuate’s open source-based platform. These offer stakeholders with content that they can easily understand, access and manipulate inside and outside the firewall which includes:

  • Employee
  • Customers
  • Partners
  • Citizens,

By the year 2010, it acquired Xenos Group Inc. (Xenos). In the same year, the Company also deployed the following:

  • Business Intelligence Reporting Tools (BIRT) onDemand
  • Actuate’s Platform as a Service Solution (PaaS) for Business Intelligence (BI)
  • Analytics and reporting

BIRT onDemand was made to support all current versions of BIRT. It comes with an intuitive user interface that delivers key features of ActuateOne, including end user configurable dashboards, in-memory analytics, ad-hoc and interactive reports.

ActuateOne

This is the Company’s flagship product. The applications were built with ActuateOne provide one user experience regardless of task or skill level. These applications are supported by one server for any deployment, including cloud and are built with one BIRT design that can access and integrate any data source, including high volume print streams. This product is used for adding data visualizations, like interactivity, dashboards, analytics, and deployment options to Web and mobile BIRT applications.

Xenos Enterprise Content Management

Xenos is a group of products which involves Xenos Enterprise Server and Xenos infoWEB. Xenos ES is a provider of both Document and Data Transformation Services which allows enterprises to lower operational costs and complexity and improve customer service. It is a scalable solution for supporting several activities such as processing, extraction, transformation, repurposing and personalization of structured and unstructured data in legacy environment.

Moreover, the Xenos Document Transformation Services transform and repurpose print stream documents for high-volume batch production printing, document proofing, mailing and online presentment.  These services allow organizations to process enormous volumes of electronic data and information at high transaction speeds.

The Company also has Xenos infoWEB which provides secure report management, distribution and online presentment. This offers a complete solution such as secure electronic presentment, multichannel report delivery, and document management. The Company is also the founder of the Eclipse BIRT open source project.

Actuate Corporation (NASDAQ: BIRT) 52 week: 4.93 – 7.01   Mkt cap: 342.99M   Shares:  49.00M

Read More
123456...Last »
 
 
 
 
 
 
Top Performing OTC Stocks: CLSN 4.020 2.3% ALN 2.190 3.8% FUEL 1.650 1.9% DSCI 11.140 7.1% PDT 12.800 0.8% FIGI 1.820 1.1% SCLN 6.400 1.4% ROSGD 1.8 22.5% ALNY 10.150 1.6% GLUU 5.9 6.5% CHCI 1.280 1.6%
HOME          STOCK WATCH          MOMENTUM STOCKS          BLOG          ABOUT          TERMS          PRIVACY          CONTACT US
By